All articles tagged with #series b funding
Ollin Biosciences raised $330 million in a Series B to push its eye-disease therapy into Phase 3 trials for diabetic macular edema and wet age-related macular degeneration, with lead investors including TCGX and ARCH Venture Partners and participation from a pension fund and crossover investors, in one of biotech’s largest Series B rounds in years.
Denver-based startup True Anomaly has raised $100 million in a Series B funding round led by Riot Ventures, with participation from several other investors. True Anomaly specializes in producing small satellites for surveillance and reconnaissance in space, primarily targeting the military and intelligence markets. The funding will be used to further advance the company's mission, including the development of its spacecraft called Jackal, training services for military satellite operators, and expanding its staff. The first two Jackal satellites are scheduled to launch in March 2024.
UK-based smallsat developer Open Cosmos has raised $50 million in a Series B funding round led by ETF Partners, Trill Impact, and A&G. The funding will be used to expand the company internationally, develop larger satellites and constellations focused on Earth observation, and create OpenConstellation, a virtual constellation where satellite operators share capacity on their Earth observation satellites. Open Cosmos aims to provide cost-effective end-to-end fully managed missions and stands out in the Earth observation sector with its agile development, diverse applications, and global partnerships. The company has already launched several smallsats and plans to move into microsatellites.